NuVasive is the lead sponsor of 9 current clinical trials in our USA register. None of its ClinicalTrials.gov trials is recruiting at the moment. All registered phases are Observational. The most-studied condition is Degenerative Disc Disease.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
A Study of Precice Intramedullary Limb Lengthening System (IMLL) Limb Lengthening Procedures
NCT06741514 · Limb Length Discrepancy
|
Observational | By invitation | 2024-03 | USA |
|
Lumbar Interbody Implant Study
NCT04418830 · Degenerative Disc Disease, Degenerative Spondylolisthesis, Degenerative Scoliosis
|
Observational | By invitation | 2020-10 | USA |
|
A Review of Precice Intramedullary Limb Lengthening (IMLL) System for Limb Lengthening Procedures in Children.
NCT06714110 · Limb Length Discrepancy
|
Observational | By invitation | 2025-03 | USA |
|
Advanced Materials Science in XLIF Study
NCT03649490 · Degenerative Disc Disease, Spondylolisthesis
|
Observational | By invitation | 2018-08 | USA |
|
Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels
NCT05691231 · ClinicalTrials.gov ↗ · Cervical Disc Disease, Degenerative Disc Disease
|
Observational | By invitation | 2023-01 | USA |
|
Posterior Cervical Fixation Study
NCT04770571 · ClinicalTrials.gov ↗ · Degenerative Disc Disease, Craniocervical Injuries, Cervical Radiculopathy
|
Observational | By invitation | 2022-05 | USA |
|
NuVasive® ACP System Study
NCT05066711 · ClinicalTrials.gov ↗ · Cervical Spondylosis, Cervical Radiculopathy, Cervical Myelopathy
|
Observational | By invitation | 2022-05 | USA |
|
Cervical Interbody Implant Study
NCT04689854 · ClinicalTrials.gov ↗ · Degenerative Disc Disease, Cervical Spinal Instability
|
Observational | By invitation | 2020-07 | USA |
|
Long-term Assessment of the Safety and Performance of the NuVasive Simplify Disc
NCT05258435 · ClinicalTrials.gov ↗ · Cervical Disc Disease, Degenerative Disc Disease
|
Observational | Active, closed | 2022-02 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 9 | 0 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Kuros Biosurgery | 2 |
| Orthofix | 1 |
| Collagen Matrix | 1 |
| Regenexx | 1 |
| Artoss | 1 |
| Providence Medical Technology | 1 |
| EicOsis Human Health | 1 |
Sponsors with the most current trials registered for this condition.
NuVasive is the lead sponsor of 9 current trials on ClinicalTrials.gov in our USA register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Not at the moment. None of its 9 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.